Bita Fakhri

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Venues

Blood advances

JCO oncology practice

Cancer

Therapeutic advances in hematology

UCSF Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF Medical Center

United States

Assistant Professor

Publications

Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice (2024)
Bita Fakhri, Victoria Wang, Gabriela Perez-Burbano, Anna Wall, Sumithra Mandrekar, Sameer A Parikh, Jennifer A Woyach, Tait Shanafelt
Pericardial events associated with ibrutinib-based therapies for chronic lymphocytic leukaemia in two landmark trials. British journal of haematology (2024)
Nilanjan Ghosh, Beenish S Manzoor, Bita Fakhri, Nnadozie Emechebe, Hasan Alhasani, Alan Skarbnik, Dureshahwar Jawaid, Mazyar Shadman
Real-world comparative effectiveness of venetoclax-obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia. British journal of haematology (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Laura Samples, Jenna M Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan C Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel A Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted A Gooley, Kellie Ryan, Frederick Lansigan, Brian T Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study. Blood advances (2024)
Laura Samples, Jenna M Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan C Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel A Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted A Gooley, Kellie Ryan, Frederick Lansigan, Brian T Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study. Blood advances (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice 20 (8) (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice 20 (8) (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Bita Fakhri, Nnadozie Emechebe, Beenish S Manzoor, Dureshahwar Jawaid, Hasan Alhasani, Melanie Edwards, Hande H Tuncer
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting. JCO oncology practice (2024)
Bita Fakhri, Weiyun Ai
Current and emerging treatment options in primary mediastinal B-cell lymphoma. Therapeutic advances in hematology 12 (2021)
Bita Fakhri, Charalambos Andreadis
The role of acalabrutinib in adults with chronic lymphocytic leukemia. Therapeutic advances in hematology 12 (2021)
Anthony R Mato, Lindsey E Roeker, Ryan Jacobs, Brian T Hill, Nicole Lamanna, Danielle Brander, Mazyar Shadman, Chaitra S Ujjani, Maryam Sarraf Yazdy, Guilherme Fleury Perini, Javier A Pinilla-Ibarz, Jacqueline Barrientos, Alan P Skarbnik, Pallawi Torka, Jeffrey J Pu, John N Allan, Satyen Gohil, Bita Fakhri, Michael Choi, Catherine C Coombs, Joanna M Rhodes, Paul M Barr, Craig A Portell, Helen M Parry, Christine A Garcia, Kate J Whitaker, Allison M Winter, Andrea Sitlinger, Sirin Khajavian, Ariel F Grajales-Cruz, Krista M Isaac, Pratik Shah, Othman Salim Akhtar, Rachael Pocock, Kentson Lam, Timothy J Voorhees, Stephen J Schuster, Thomas D Rodgers, Christopher Paul Fox, Nicolás Martinez-Calle, Talha Munir, Erica B Bhavsar, Neil Bailey, Jason C Lee, Hanna B Weissbrot, Chadi Nabhan, Julie M Goodfriend, Amber C King, Andrew D Zelenetz, Colleen Dorsey, Kayla Bigelow, Bruce D Cheson, Toby Andrew Eyre
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Emily C Ayers, Shaoying Li, L Jeffrey Medeiros, David A Bond, Kami J Maddocks, Pallawi Torka, Angel Mier Hicks, Madeira Curry, Nina D Wagner-Johnston, Reem Karmali, Amir Behdad, Bita Fakhri, Brad S Kahl, Michael C Churnetski, Jonathon B Cohen, Nishitha M Reddy, Dipenkumar Modi, Radhakrishnan Ramchandren, Christina Howlett, Lori A Leslie, Samuel Cytryn, Catherine S Diefenbach, Rawan Faramand, Julio C Chavez, Adam J Olszewski, Yang Liu, Stefan K Barta, Dhruvika Mukhija, Brian T Hill, Helen Ma, Jennifer E Amengual, Sunita Nathan, Sarit E Assouline, Victor M Orellana-Noia, Craig A Portell, Ashwin Chandar, Kevin A David, Anshu Giri, Brian T Hess, Daniel J Landsburg
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure. Cancer 126 (2) (2019)
Bita Fakhri, Mark A Fiala, Nina Shah, Ravi Vij, Tanya M Wildes
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database. Cancer 126 (4) (2019)
Bita Fakhri, Mark Fiala, Michael Slade, Peter Westervelt, Armin Ghobadi
Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML. Case reports in hematology 2017 (2017)

Bita Fakhri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bita Fakhri